BeiGene Announces Clinical Data on Tislelizumab and Pamiparib Presented at the European Society for Medical Oncology (ESMO) Congress 2019
30 sept. 2019 06h00 HE
|
BeiGene, LTD.
CAMBRIDGE, Mass. and BEIJING, China, Sept. 30, 2019 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and...
BeiGene Announces Clinical Data on Tislelizumab and Pamiparib to Be Presented at the European Society for Medical Oncology (ESMO) Congress 2019
26 sept. 2019 18h05 HE
|
BeiGene, LTD.
CAMBRIDGE, Mass. and BEIJING, China, Sept. 26, 2019 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and...
Persbericht Biocartis NV: Vijf Idylla™ performantie studies worden gepresenteerd op het ‘European Society for Medical Oncology’ (ESMO) congres
23 sept. 2019 01h00 HE
|
Biocartis NV
PERSBERICHT23 september 2019, 07:00 CEST Mechelen, België, 23 september 2019 – Biocartis Group NV (de 'Vennootschap' of 'Biocartis'), een innovatief bedrijf in de moleculaire diagnostiek...
Press Release Biocartis NV: Five Idylla™ Performance Studies to be Presented at ‘European Society for Medical Oncology’ congress
23 sept. 2019 01h00 HE
|
Biocartis NV
PRESS RELEASE23 September 2019, 07:00 CEST Mechelen, Belgium, 23 September 2019 – Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative molecular diagnostics company (Euronext...